Andrew Joseph
STAT
Boston, MA, United States
Contact Andrew
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Andrew:
Q&A: Califf on obesity drugs, advisory panels, and how threats hurt recruitment at FDA
FDA Commissioner Robert Califf: "The most important thing to me about the advisory committees is that the purpose is not to take a vote on the approval of a product. The purpose to me is to get the advice of experts of various types." → Read More
U.N.: Progress on reducing global maternal mortality has stalled since 2015
The progress the world has made in reducing maternal mortality has stalled in recent years, with some regions — including Europe and Northern America — backsliding since 2015, according to a new report. → Read More
Pharmalittle: New medication appears to stave off type 1 diabetes; CRISPR pioneer founds another startup
A new medication, an antibody therapy that blocks T cells, appears to be helping stave off the development of type 1 diabetes. → Read More
Scientific institutions must embrace antiracist policies, National Academies report urges
A new National Academies report stresses that the barriers facing students, trainees, and researchers of color don’t go away once they have their foot in the door. → Read More
Survey: Nearly 3 in 5 teen girls felt persistently sad or hopeless in 2021
A new CDC survey finds that nearly 3 in 5 teen girls felt persistently sad or hopeless in 2021, up 60% from a decade earlier. → Read More
They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help
“For so long, it felt like those of us in the 10% were watching innovation happening around us,” said a patient with cystic fibrosis. “And for the first time, it feels like we’re the focus.” → Read More
Leading ALS advocacy group roiled by infighting over money and priorities
A blistering battle has broken out between the ALS Association and more than a dozen of its state and local chapters. → Read More
FDA pulls Evusheld authorization as coronavirus evolution quashes another therapy
Evusheld is the latest antibody therapy to be rendered ineffective by coronavirus mutations. → Read More
Loan repayment program seeks to bolster infectious disease field
The hope is that a loan repayment program, which would offer up to $50,000 a year for up to three years, could be enough to attract more people to the infectious disease field. → Read More
Routine vaccinations drop among U.S. kindergartners for the third year in a row
Fewer U.S. kindergartners are getting standard childhood vaccines, fueling concerns about anti-vaccine sentiments stirred up by Covid-19. → Read More
The pandemic showed the power of viral sequencing. Now the U.K. plans to decode other respiratory bugs
Researchers hope the initiative will enable them to monitor viruses in the U.K. as they change, alert them to any worrisome mutations, and get tipped to the emergence of new viruses. → Read More
A year after a nurse’s loss to suicide, his friends are building out a peer support network
“There’s been more people than I ever realized out there in the health care world looking for support,” a nurse said. → Read More
Covid’s winter surge is poised to exceed summer peak
Even if Covid will be little more than a nuisance for many on an individual level, others who may not realize the virus remains a threat to them — particularly older people — might also be shrugging off the risk. → Read More
Under new rules, methadone clinics can offer more take-home doses. Will they?
The tension between looser rules on paper and the resistance among some clinics to take-home methadone will only intensify. → Read More
Science, Cell issue notices of concern on challenged papers co-authored by Stanford president
Two leading journals issued “expressions of concern” on papers co-authored by the Stanford president, who is under investigation over allegations of research misconduct. → Read More
England to sequence genomes of 100,000 newborns, to try to catch illness earlier
England is launching a pilot program sequencing the genomes of up to 100,000 newborns to see if such a strategy can speed up the detection of genetic illnesses. → Read More
Limits of ‘Fauci effect’: infectious disease applicants plummet, and hospitals are scrambling
“Being at the forefront of the pandemic, and being underappreciated, might be the killer combination,” said a director of an infectious disease fellowship. → Read More
In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the same
“It’s crazy this stuff, it’s burning through our bodies,” said a man who encountered the animal tranquilizer xylazine in the drugs he used. → Read More
Covid evolution wipes out another antibody treatment, threatening the country’s medicine cabinet
The FDA ended its emergency authorization for the only remaining Covid-19 monoclonal therapy cleared for use, saying variants that render it ineffective are now dominant in the United States. → Read More
Stanford is investigating its president over allegations of research misconduct
Stanford is investigating its president, Marc Tessier-Lavigne, over allegations that papers on which he is a co-author include altered images. → Read More